Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma

Norbert Hilf; Sabrina Kuttruff-Coqui; Katrin Frenzel; Valesca Bukur; Stefan Stevanović; Cecile Gouttefangeas; Michael Platten; Ghazaleh Tabatabai; Valerie Dutoit; Sjoerd H van der Burg; Per Thor Straten; Francisco Martinez-Ricarte; Berta Ponsati; Hideho Okada; Ulrik Lassen; Arie Admon; Christian H Ottensmeier; Alexander Ulges; Sebastian Kreiter; Andreas von Deimling; Marco Skardelly; Denis Migliorini; Judith R Kroep; Manja Idorn; Jordi Rodon; Jordi Piro; Hans S Poulsen; Bracha Shraibman; Katy McCann; Regina Mendrzyk; Martin Lower; Monika Stieglbauer; Cedrik M Britten; David Capper; Marij J P Welters; Juan Sahuquillo; Katharina Kiesel; Evelyna Derhovanessian; Elisa Rusch; Lukas Bunse; Colette Song; Sandra Heesch; Claudia Wagner; Alexandra Kemmer-Bruck; Jorg Ludwig; John C Castle; Oliver Schoor; Arbel D Tadmor; Edward Green; Jens Fritsche; Miriam Meyer; Nina Pawlowski; Sonja Dorner; Franziska Hoffgaard; Bernhard Rossler; Dominik Maurer; Toni Weinschenk; Carsten Reinhardt; Christoph Huber; Hans-Georg Rammensee; Harpreet Singh-Jasuja; Ugur Sahin; Pierre-Yves Dietrich; Wolfgang Wick

doi:10.1038/s41586-019-0959-z

Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma

Nature. 2019 Feb;566(7745):E13. doi: 10.1038/s41586-019-0959-z.

Authors

Norbert Hilf^#¹, Sabrina Kuttruff-Coqui^#¹, Katrin Frenzel², Valesca Bukur², Stefan Stevanović^{3

4}, Cecile Gouttefangeas^{3

4

5}, Michael Platten^{6

7

8}, Ghazaleh Tabatabai^{3

4

9}, Valerie Dutoit¹⁰, Sjoerd H van der Burg^{5

11}, Per Thor Straten^{5

12

13}, Francisco Martinez-Ricarte¹⁴, Berta Ponsati¹⁵, Hideho Okada^{16

17}, Ulrik Lassen¹⁸, Arie Admon¹⁹, Christian H Ottensmeier²⁰, Alexander Ulges¹, Sebastian Kreiter^{2

5}, Andreas von Deimling^{6

7}, Marco Skardelly⁹, Denis Migliorini¹⁰, Judith R Kroep¹¹, Manja Idorn^{12

13}, Jordi Rodon^{14

21}, Jordi Piro¹⁵, Hans S Poulsen¹⁸, Bracha Shraibman¹⁹, Katy McCann²⁰, Regina Mendrzyk¹, Martin Lower², Monika Stieglbauer^{3

5}, Cedrik M Britten^{2

5

22}, David Capper^{6

7

23}, Marij J P Welters^{5

11}, Juan Sahuquillo¹⁴, Katharina Kiesel¹, Evelyna Derhovanessian², Elisa Rusch^{3

5}, Lukas Bunse^{6

7}, Colette Song¹, Sandra Heesch², Claudia Wagner¹, Alexandra Kemmer-Bruck², Jorg Ludwig¹, John C Castle^{2

24}, Oliver Schoor¹, Arbel D Tadmor²⁵, Edward Green^{7

8}, Jens Fritsche¹, Miriam Meyer¹, Nina Pawlowski¹, Sonja Dorner¹, Franziska Hoffgaard¹, Bernhard Rossler¹, Dominik Maurer¹, Toni Weinschenk¹, Carsten Reinhardt¹, Christoph Huber², Hans-Georg Rammensee^{3

4}, Harpreet Singh-Jasuja¹, Ugur Sahin², Pierre-Yves Dietrich¹⁰, Wolfgang Wick^{26

27}

Affiliations

¹ Immatics Biotechnologies GmbH, Tübingen, Germany.
² BioNTech AG, Mainz, Germany.
³ Eberhard Karls Universität Tübingen, Tübingen, Germany.
⁴ German Cancer Consortium (DKTK), German Cancer Research Center Partner Site Tübingen, Tübingen, Germany.
⁵ CIMT/CIP - Association for Cancer Immunotherapy, working group Cancer Immunoguiding Program, Mainz, Germany.
⁶ University Hospital Heidelberg, Heidelberg, Germany.
⁷ German Cancer Consortium (DKTK), German Cancer Research Center, Heidelberg, Germany.
⁸ Medical Faculty Mannheim, Mannheim, Germany.
⁹ University Hospital Tübingen, Tübingen, Germany.
¹⁰ Geneva University Hospital, Geneva, Switzerland.
¹¹ Leiden University Medical Center, Leiden, The Netherlands.
¹² Center for Cancer Immune Therapy (CCIT), Department of Hematology, University Hospital Herlev, Herlev, Denmark.
¹³ Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
¹⁴ Vall d'Hebron University Hospital, Barcelona, Spain.
¹⁵ BCN Peptides SA, Barcelona, Spain.
¹⁶ University of California, San Francisco, San Francisco, CA, USA.
¹⁷ Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.
¹⁸ Ringhospitalet, Copenhagen, Denmark.
¹⁹ Technion - Israel Institute of Technology, Haifa, Israel.
²⁰ University of Southampton, Southampton, UK.
²¹ M. D. Anderson Cancer Center, University of Texas, Houston, TX, USA.
²² Oncology R&D, GlaxoSmithKline, Stevenage, UK.
²³ Charité, University Medicine Berlin, Berlin, Germany.
²⁴ Agenus Inc, Lexington, KY, USA.
²⁵ TRON GmbH - Translational Oncology at the University Medical Center of Johannes Gutenberg University, Mainz, Germany.
²⁶ University Hospital Heidelberg, Heidelberg, Germany. wolfgang.wick@med.uni-heidelberg.de.
²⁷ German Cancer Consortium (DKTK), German Cancer Research Center, Heidelberg, Germany. wolfgang.wick@med.uni-heidelberg.de.

^# Contributed equally.

PMID: 30733620
DOI: 10.1038/s41586-019-0959-z

Abstract

The additional author support information was erroneously omitted from the Supplementary Information. This has been corrected online.

Publication types

Published Erratum